This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Rexgenero Ltd.

Drug Names(s): REX001, REX 001, Rexmyelocel-T

Description: REX-001 (Rexmyelocel-T) is derived from autologous bone marrow mononuclear cells (BM-MNCs), under development by Rexgenero.

REX-001 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug